Kensington Investment Counsel, LLC Tandem Diabetes Care Inc Transaction History

Kensington Investment Counsel, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$101.89 - $150.09 $1.47 Million - $2.16 Million	-14,403 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $211,778 - $274,552	1,792 Added 14.21%	14,403 $2.17 Million
Q2 2021 Aug 13, 2021	BUY	$77.0 - $100.19 $24,255 - $31,559	315 Added 2.56%	12,611 $1.23 Million
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $85,994 - $110,391	1,058 Added 9.41%	12,296 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$86.4 - $121.75 $970,963 - $1.37 Million	11,238 New	11,238 $1.08 Million

312

73.1M

3.25M

250K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.6B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Kensington Investment Counsel, LLC with notifications on news.